Each Human Being Has The Right To Quality Life: Reducing Health
Disparities

Pictured: Dr Simone Badal fine adjusting a microscope at the ACRJ Cell Culture lab.

Our Cell Culture Lab

The ability to replicate cellular in vivo growth conditions in vitro over prolonged periods of time has been a challenging feat, one that dates to the late nineteenth century when Wilhelm Roux attempted to maintain chicken embryonic cells in a saline buffer for a few days. Subsequently, Ross Harrison successfully maintained frog nerve cells in 1907 for a short while using the hanging drop method. The successful growth of mammalian cells in culture was believed to hold significant promise in understanding various diseases towards their amelioration, a solution being tissue cloning.

Continue reading

After decades of momentous attempts, it wasn’t until 1952 that the first human immortal cell line was developed by a woman called Henrietta Lacks. Some say success was primarily due to the aggressive nature of her tumour. Notwithstanding, scientists by then had refined culture mediums that contained necessary ingredients in appropriate proportions aimed at optimizing cell growth and survival coupled with perfecting additional growing conditions. The development of mammalian cell lines has thus far contributed to the polio vaccine, gene mapping, and uncovering of secrets of cancer and viruses. It however continues to be challenging to develop new cell lines despite the many hurdles that have already been overcome, highlighting the selectiveness of each cell line. Currently, there is a less than 10% success rate in generating prostate cancer cell lines. There is now a paradigm shift from the lock and key-approach towards disease treatment to a personalized one. Achieving the latter involves DNA sequencing from various populous and the human genome project has made significant strides towards this end. However, what is now evident is the disparity in information for men of African ancestry (MAA) compared to men of European ancestry (MEA). Of note, is the higher incidence and mortality rates of prostate cancer for MAA compared to MEA. Disparities of this nature are also evident between women of African ancestry (WAA) and women of European ancestry (WEA) with breast cancer. Although WEA experiences higher incidence, WAA still experiences higher rates of mortality. In particular, Jamaican women on average are diagnosed with breast cancer at a younger age relative to the global population. It is on this basis that the ACRJ lab was founded as it has embarked on the quest to develop novel human cell lines from the Jamaican people, an area that will be expanded to the Caribbean. These tools will become available to the global scientific community for screening, it is believed that these tools will contribute to understanding the whys for these current disparities and pave the way for personalized solutions.

ACRJ will be the leading anticancer research facility in the region to
facilitate Avant-garde anticancer research that will increase the understanding of cancer
disparities and transition the region’s natural products to safer and personalized anticancer
therapies; needed to improve quality of life for all patients with cancer.

– Photos of the ACRJ Cell Culture Lab –
Located at the UWI Mona Campus, the lab is a world-leading and renowned cell culture research facility equipped with first-class technologies and infrastructure for in-depth scientific experiments, observations, reporting and analysis.

Our Projects

Making the world cancer-free one research at a time

Single Cell Sequencing

It is understood that genetic factors alone cannot account for the disproportionate disease outcomes faced by diverse patient populations.

African Cancer Genome Registry (ACGR)

Clinicopathology and molecular biology of cancers’ research between races has been limited due to poor representation in findings from persons of African Ancestry.

International Registry in Men with Advanced Prostate Cancer (IRONMAN)

IRONMAN is an international study that is focused on amassing the largest cohort of men (5000) with advanced prostate cancer.

Cell Line Development

Cancer continues to be an important disease as it holds the number two spot as the leading cause of death worldwide. Among the most prevalent are breast and prostate cancer, with incidences of 2.26 million and 1.41 million cases, respectively (who, 2022).

Papers

The need for cell lines from diverse ethnic backgrounds for prostate cancer research

01

Disparities in prostate cancer incidence and mortality rates: Solvable or not?

02

Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase

03

Racial disparities in breast cancer preclinical and clinical models – Breast Cancer Research

04

Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient

05

Ethnically diverse cancer cell lines for drug testing – Nature Reviews Cancer

06

Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient – PubMed

07

The importance of ancestry and
diversity in cell line collection and
analysis for people of African ancestry

08

We have launch the ACRJ Foundation to offers assistance with the completion of education goals, vocational skills and mentorship.